Browse
related articles
UAE hormonal drug discrepancies
- United Arab Emirates: Saturday, October 21 - 2006 at 08:06
UAE authorities are evaluating a drug for hormonal imbalances in women after its Arabic and English instructions contained discrepancies, reported Gulf News. The English instructions for Progyluton advised users to stop taking it if irregular bleeding occurs, only after consulting a doctor, while the Arabic version recommends an immediate stop. The English version also advises users to stop taking the drug six weeks before surgery, while the Arabic version suggests six months.
Also consider reading:
Today's top stories
Week's top stories
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
- » Construction works in 19 stations on Dubai Metro Red Line completed, operation to start in February 2010
- » Saudi Telecom Company signs partnership agreement with Real Madrid Football Club
- » HH Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum opens INDEX 2009, sponsored by Al Nakheel
- » A bright future forecasted for UAE economy and higher education
- » Nawras introduces Nawras Mobile TV
Jonathan Sheikh-Miller, Deputy EditorSaturday, October 21 - 2006 at 08:06 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
This article was updated on Thu Nov 16 2006.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
It looks like you are using a Mac - check out our 
Web Feeds